These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 22395091)

  • 21. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A proteomic profile of washing fluid from the colorectal tract to search for potential biomarkers of colon cancer.
    Giusti L; Iacconi P; Da Valle Y; Ciregia F; Ventroni T; Donadio E; Giannaccini G; Chiarugi M; Torregrossa L; Proietti A; Basolo F; Lucacchini A
    Mol Biosyst; 2012 Apr; 8(4):1088-99. PubMed ID: 22294321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary metabonomic study on colorectal cancer.
    Qiu Y; Cai G; Su M; Chen T; Liu Y; Xu Y; Ni Y; Zhao A; Cai S; Xu LX; Jia W
    J Proteome Res; 2010 Mar; 9(3):1627-34. PubMed ID: 20121166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.
    Ma Y; Peng J; Liu W; Zhang P; Huang L; Gao B; Shen T; Zhou Y; Chen H; Chu Z; Zhang M; Qin H
    Mol Cell Proteomics; 2009 Aug; 8(8):1878-90. PubMed ID: 19460759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preoperative molecular staging of colorectal cancers by CM10 ProteinChip and SELDI-TOF-MS analysis].
    Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):753-7. PubMed ID: 17366787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.
    An Z; Chen Y; Zhang R; Song Y; Sun J; He J; Bai J; Dong L; Zhan Q; Abliz Z
    J Proteome Res; 2010 Aug; 9(8):4071-81. PubMed ID: 20560663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal cancer detection using targeted serum metabolic profiling.
    Zhu J; Djukovic D; Deng L; Gu H; Himmati F; Chiorean EG; Raftery D
    J Proteome Res; 2014 Sep; 13(9):4120-30. PubMed ID: 25126899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application of serum protein pattern model in diagnosis of colorectal cancer].
    Chen YD; Zheng S; Yu JK; Hu X
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):417-20. PubMed ID: 15355647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
    Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
    Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
    de Wit M; Jimenez CR; Carvalho B; Belien JA; Delis-van Diemen PM; Mongera S; Piersma SR; Vikas M; Navani S; Pontén F; Meijer GA; Fijneman RJ
    Gut; 2012 Jun; 61(6):855-64. PubMed ID: 21890811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of S100A8 and S100A9 as serological markers for colorectal cancer.
    Kim HJ; Kang HJ; Lee H; Lee ST; Yu MH; Kim H; Lee C
    J Proteome Res; 2009 Mar; 8(3):1368-79. PubMed ID: 19186948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment.
    Bijian K; Mlynarek AM; Balys RL; Jie S; Xu Y; Hier MP; Black MJ; Di Falco MR; LaBoissiere S; Alaoui-Jamali MA
    J Proteome Res; 2009 May; 8(5):2173-85. PubMed ID: 19284786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage mannose receptor 1 and S100A9 were identified as serum diagnostic biomarkers for colorectal cancer through a label-free quantitative proteomic analysis.
    Fan NJ; Chen HM; Song W; Zhang ZY; Zhang MD; Feng LY; Gao CF
    Cancer Biomark; 2016; 16(2):235-43. PubMed ID: 26682511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of autoantibody signatures as biomarkers for early detection of colorectal carcinoma.
    Chang W; Wu L; Cao F; Liu Y; Ma L; Wang M; Zhao D; Li P; Zhang Q; Tan X; Yu Y; Lou Z; Zhao J; Zhang H; Fu C; Cao G
    Clin Cancer Res; 2011 Sep; 17(17):5715-24. PubMed ID: 21771877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic-based analysis for identification of potential serum biomarkers in gallbladder cancer.
    Tan Y; Ma SY; Wang FQ; Meng HP; Mei C; Liu A; Wu HR
    Oncol Rep; 2011 Oct; 26(4):853-9. PubMed ID: 21687958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomics in diagnosis and biomarker discovery of colorectal cancer.
    Zhang A; Sun H; Yan G; Wang P; Han Y; Wang X
    Cancer Lett; 2014 Apr; 345(1):17-20. PubMed ID: 24333717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case-controlled identification of colorectal cancer based on proteomic profiles and the potential for screening.
    Huijbers A; Mesker WE; Mertens BJ; Bladergroen MR; Deelder AM; van der Burgt YE; Tollenaar RA
    Colorectal Dis; 2014 Nov; 16(11):907-13. PubMed ID: 25243779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A quantitative multimodal metabolomic assay for colorectal cancer.
    Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
    BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.